A series of febrifugine analogues were designed and synthesized. Antimalarial activity evaluation of the synthetic compounds indicated that these derivatives had a strong inhibition against both chloroquine-sensitive and -resistant Plasmodium falciparum parasites. Many of them were found to be more active than febrifugine hydrochloride. The tested analogues had also a significant cytotoxicity against four cancer cell lines (KB, MCF7, LU1 and HepG2). Among the synthetic analogues, two compounds 17b and 17h displayed a moderate cytotoxicity while they exhibited a remarkable antimalarial activity.
Febrifugine (1), a quinazoline-type alkaloid, was first isolated from Dichroa febrifuga [1a,b] , a plant found in several countries in Asia and used by local people as medicine against fevers caused by malaria parasites. Febrifugine has powerful in vitro antimalarial activity against both chloroquine-sensitive Plasmodium falciparum FCR-3 and chloroquine resistant P. falciparum K1. Although febrifugine (1) possesses interesting biological profiles and has been used historically as a herbal remedy, it has serious side effects such as nausea, vomiting, and liver toxicity, which have precluded its use as an antimalarial drug [2a,b] . However, the pharmacological interest in febrifugine encouraged the pursuit of suitable lead compounds based on febrifugine for the development of novel drugs. Many analogues of febrifugine have been prepared and evaluated for their biological activities. Among them, halofuginone (2), the halogenated derivative of febrifugine, has been tested in clinical trials for potential therapeutic applications in cancer and fibrotic disease [3a-d] . In this communication, we report the synthesis of a series of febrifugine analogues with modification of the quinazoline ring, and the evaluation of their biological activities.
The preparation of the febrifugine analogues is described in Schemes 1 and 2. The quinazolin-4-ones (4a-h) were first prepared starting from the corresponding 2-amino-benzoic acid derivatives. By using the modified reported method [4a,b] , the quinazolin-4ones 4a-h were successfully obtained in high yields (85-96%) by condensation cyclization of 3a-h with excess of formamide under microwave irradiation. It was found that when the reaction was performed by heating at 150 -170 o C without microwave assistance, the quinazolin-4-ones 4a-h were formed in lower yields (60-85%) and with longer reaction times (8 h -14 h). In the next steps, the valerolactam derivative 11 was synthesized from the commercial available material, L-glutamic acid (5) through six steps [5] . In these synthetic procedures, the protection of 6 with an acetyl group would facilitate the protection/deprotection processes in comparison with the previous reports in which the hydroxyl group of 6 was protected with either TMS or MOM groups [5, 6] . Treatment of the lactam compound 11 with (Boc) 2 O afforded the intermediate 12, which was then reacted with allyltrimethylsilane in the presence of BF 3 .Et 2 O to furnish compound 13. Configuration at C-2 of 13 was revealed by analysis of the NMR signal of H-3, which had an anti (J = 11.5 Hz) and two gauche (J = 4.7 Hz) coupling constants. This observation suggested that H-3 had an axial disposition while H-2 had an equatorial orientation on the ring. The cis-relationship was thus assigned for H-2/H-3 of 13. Epoxidation of 13 with m-chloroperbenzoic acid (m-CPBA) in CH 2 Cl 2 provided the diastereoisomeric mixture 14 [6] . With the epoxide 14 in hand, a series of alcohol intermediates 15a-h were synthesized by epoxide ring opening with the different quinazolin-4-ones 4a-h. Compounds 15a-h were obtained as a mixture of two diastereoisomers, as observed in the previous report [7] . In recent years, application of ionic liquids in organic synthesis has attracted considerable attention. This green chemistry approach could avoid the use of toxic organic solvents that damage the environment. In the previous report, it was demonstrated that the oxidation of alcohols into ketones could be achieved by using the Dess-Martin periodinane reagent in [bmim]BF 4 and [bmim]PF 6 ionic liquids [8] . Using this method for oxidation of the diastereoisomeric mixture 15a-h under microwave irradiation afforded the corresponding ketone compounds 16a-h in high yields. Under microwave assistance, the ketone derivatives 16a-h were formed faster, compared with the reported procedure [7] . Finally, the acetyl and Boc groups were successively removed to provide the febrifugine hydrochloride analogues 17a-h. In addition, febrifugine hydrochloride (1a) was also prepared, according to the same protocols. The trans-diaxial relationship between H-2′′ and H-3′′ was clearly observed for the analogues 17a-h as determined by analysis of the NMR signal of the proton H-3′′, which had two anti (J = 9.0 -9.5 Hz) and a gauche (J = 3.5 -4.0 Hz) coupling constants. Thus, during the deprotection processes, an epimerization at the C-2′′ of 16a-h was noted. This could be due to the interconversion between febrifugine and isofebrifugine forms [5, 9] . Due to the known 2S configuration of L-glutamic acid, the S-configuration was assigned for both C-2′′ and C-3′′ of 17a-h.
The synthetic compounds were evaluated for their antimalarial activity toward chloroquine-sensitive (T96) and chloroquineresistant P. falciparum, and for their cytotoxicity against four cancer cell lines, KB (mouth epidermal carcinoma cells), MCF7 (human breast cancer cells), LU1 (human lung cancer cells) and HepG2 (human hepatocellular liver carcinoma cell line). As expected, all the synthetic compounds had a strong antimalarial activity against both chloroquine-sensitive and -resistant strains of P. falciparum (Table 1 ). Compounds 17a-e were found to be more active than febrifugine hydrochloride (1a) against both sensitive and resistant strains. Several analogues had also significant cytotoxicity against four cancer cell lines. Among the tested samples, compounds 17b and 17h displayed moderate cytotoxicity while they had a remarkable antimalarial activity. This observation suggested that the antimalarial activity of these two analogues should not result from their cytotoxic property. 
Synthesis of compounds 8-13:
These compounds were prepared according to the previously reported procedures [5] . 
Procedure for synthesis of 14:
To a stirred solution of 13 (4.5 g, 18.2 mmol) in CHCl 3 (30 mL) was added m-CPBA (5.0 g, 2.44 mmol). The mixture was stirred at rt for 10 h then washed with aqueous 10% NaHCO 3 (3 × 15 mL). The CHCl 3 solution was concentrated under diminished pressure and the residue was purified by CC (n-hexane/EtOAc gradient), providing 14 (3.84 g, 70.5%)as a mixture of two isomers with a ratio of 7/3. This mixture was used for next steps without separation.
General procedure for synthesis of 15a-h:
To a stirred solution of the corresponding quinazolin-4-ones 4a-h (1.0 mmol) in EtOH (10 mL) were added 14 (0.5 eq) and triethylamine (0.5 eq). The mixture was heated at 60 o C for 12 h, and then concentrated in vacuum to dryness. The residue was purified by CC on Sephadex LH-20 to afford the alcohols 15a-h. The 1D NMR spectra of these 
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General procedure for synthesis of 16a-h:
A solution of the corresponding alcohols 15a-h (1.0 mmol) and Dess-Martin periodinane (3.0 eq) were added in ionic liquid1-butyl-3methylimidazolium tetrafluoroborate [Bmim]BF 4 -(4.0eq). The mixture was irradiated by microwave at 90 W for 15 min. The mixture was extracted with Et 2 O (5 × 30 mL). The Et 2 O solution was dried over anhydrous Na 2 SO 4 and concentrated to dryness. The crude product was purified by CC (CH 2 Cl 2 /EtOAc gradient) to afford compounds 16a-h in 61-80% yields. Similar to compounds 15a-h, due to the ring inversion, broad signals were observed for 16a-h in their 1D NMR spectra.
General procedure for synthesis of 17a-h:
To a stirred solution of the corresponding ketone (0.3mmol) in a mixture of MeOH/H 2 O (1.5/0.2, v/v) was added sodium carbonate (2.0eq). The solution was stirred at rt for 1 h then concentrated under diminished pressure to remove MeOH. Water (10 mL) was added and the mixture was extracted with CH 2 Cl 2 (3 × 15 mL). The CH 2 Cl 2 solution was concentrated to dryness. The residue was dissolved in CHCl 3 (1.5 mL) and cooled to 0 o C. To this solution, concentrated HCl (4 eq) was added at 0 o C. The mixture was then stirred at rt for 4 h, and concentrated to dryness. The residue was recrystallized in acetone to provide febrifugine hydrochloride analogues 17a-h. 
Compound 17a

Compound 17c
White solid; yield 77%. MP: 207-208°C. 
Febrifugine hydrochloride (1a)
White solid; yield 82%. MP: 282-283°C. NMR data are in agreement with the reported values [10] .
Cytotoxic activity assay:
The cytotoxicity assays were carried out in 96-well microtiter plates against cancer cells (KB, LU-1, HepG2 and MCF-7), using a modification of the published method [11] . Ellipticine was used as a reference compound.
Antimalarial activity assay:
Antiplasmodial activity of the samples was determined against chloroquine-sensitive (T96) and chloroquine-resistant (K1) P. falciparum, according to the reported method [12] . Chloroquine was used as positive control.
